Ucla Biomedical Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UCLA BIOMEDICAL, and what generic and branded alternatives to UCLA BIOMEDICAL drugs are available?
UCLA BIOMEDICAL has two approved drugs.
Summary for Ucla Biomedical
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Ucla Biomedical
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucla Biomedical | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203811-001 | Jun 27, 2013 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ucla Biomedical | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203812-001 | Jun 27, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
